From Free Rider to Innovator: The Rise of China's Drug Development
收藏NBER2026-03-01 更新2026-03-28 收录
下载链接：
https://www.nber.org/papers/w34977
下载链接
链接失效反馈官方服务：
资源简介：
This paper examines Chinas transition from pharmaceutical free rider to global innovator over the last decade. In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume. To study this transformation, we compile a
提供机构：
美国国家经济研究局
创建时间：
2026-03-01
